News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

20/20 GeneSystems, Inc. Release: New Multiplex Tissue Biomarker Technology Launched to Advance Personalized Medicine



9/14/2010 11:52:33 AM

ARLINGTON, Va.--(BUSINESS WIRE)--20/20 GeneSystems, Inc. (“20/20” ) announced today at ADAPT 2010, an industry meeting focusing on advancing personalized medicine, the commercial launch of their patented technology for biomarker identification in tumors and other tissue samples. 20/20 is currently offering the technology to industry and academic researchers under service contracts.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES